SCHEMBL30775296

SCHEMBL30775296

CN(C)c1ncc(F)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.48
HSD17B10 Q99714 8/20 0.48
ALOX15 P16050 2/20 0.48
KDM4E B2RXH2 1/20 0.48
KCNH2 Q12809 1/20 0.46
GRM5 P41594 2/20 0.43
CYP1A2 P05177 9/20 0.38
LMNA P02545 1/20 0.38
THRB P10828 1/20 0.38
BLM P54132 1/20 0.38
CREBBP Q92793 1/20 0.38
HPGD P15428 5/20 0.36
CASP1 P29466 8/20 0.35
CASP7 P55210 8/20 0.35
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
USP2 O75604 4/20 0.35
GLA P06280 1/20 0.35
TSHR P16473 4/20 0.34
CYP2D6 P10635 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21729931 0.77 ALDH1A1 (0.46) ALDH1A1HSD17B10ALOX15KDM4EKCNH2
SCHEMBL18861713 0.75 KDM4E (0.33) ALDH1A1HSD17B10ALOX15KDM4EKCNH2
SCHEMBL3129653 0.74 HSD17B10 (0.50) ALDH1A1HSD17B10ALOX15KDM4EKCNH2
SCHEMBL3129639 0.72 HSD17B10 (0.48) ALDH1A1HSD17B10ALOX15KDM4EKCNH2
SCHEMBL4926690 0.72 HSD17B10 (0.54) ALDH1A1HSD17B10ALOX15KDM4EKCNH2
SCHEMBL29294865 0.72 HSD17B10 (0.48) ALDH1A1HSD17B10ALOX15KDM4EKCNH2
SCHEMBL5132886 0.72 ALDH1A1 (0.48) ALDH1A1HSD17B10ALOX15KDM4EKCNH2
SCHEMBL15360282 0.72 ALDH1A1 (0.43) ALDH1A1HSD17B10ALOX15KDM4EKCNH2
SCHEMBL14234049 0.70 ALDH1A1 (0.46) ALDH1A1HSD17B10ALOX15KDM4EKCNH2
Hydrochloric Acid SCHEMBL30189824 0.70 ALDH1A1 (0.46) ALDH1A1HSD17B10ALOX15KDM4EKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025884-A1 COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF DONG-A ST CO., LTD. (KR) 2024-01-25 US claimed
US-12240836-B2 Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof DONG-A ST CO., LTD. (KR) 2025-03-04 US disclosed
US-20240025884-A1 COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF DONG-A ST CO., LTD. (KR) 2024-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12240836-B2 Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof EIF2AK4, GCN1, GCGR ALDH1A1 3927/4885HSD17B10 289/4885ALOX15 627/4885
US-20240025884-A1 COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF EIF2AK4, GCN1, GCGR ALDH1A1 3927/4885HSD17B10 289/4885ALOX15 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.